San Francisco, California — January 12, 2020 — Ideaship, a patent leveraged venture capital firm that provides patent development support to early-stage startups, announced it has invested in 8chili, Inc. The investment will assist 8chili’s mission to re-imagine surgical training and surgeries with 8chili’s patent pending device, NAVIX AIR.

“8chili is revolutionizing the way that surgeons operate through their novel virtual and augmented reality technology that enables remote procedure training, blending artificial intelligence, 3D live streaming, and real-time scene reconstruction. We are honored to be involved with 8chili as they look toward changing the way surgeons learn and operate,” said Robert Bell, Ideaship Venture Partner. 8chili Logo

“Ideaship brings investment and strategic execution to this relationship. We believe the 8chili team along with GTT Group’s foundational patent asset venture practice and Panasonic’s world-leading patent department will accelerate the creation of a valuable IP portfolio at 8chili,” said Aravind Upadhyaya, CEO of 8chili.

About 8chili

8chili is a deeptech startup based in San Francisco, California that is transforming training and collaboration space with their proprietary non-invasive device AIR. The company’s initial focus is in healthcare with a mission to increase patient satisfaction and workplace efficiency by enabling access to cutting edge mixed reality applications like patient engagement, pre-op planning, training and remote collaboration. 8chili’s unique 3D data lake creates a hyper-personalized learning experience that will help train medical robots to perform safe surgeries in the future.

To learn more visit

About Ideaship

Ideaship provides patent development capital to early-stage ventures.

Ideaship is a collaboration between Global Technology Transfer Group (GTT Group) and Panasonic Intellectual Property Corporation of America (PIPCA). Ideaship combines GTT Group’s patent experience with PIPCA’s leading patent department expertise, achieving enterprise value premiums.

For more information, please visit